CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$4,613,026
-22.8%
835,693
+19.5%
0.00%
-50.0%
Q2 2023$5,973,661
-2.8%
699,492
+4.6%
0.00%0.0%
Q1 2023$6,145,114
-9.9%
668,674
+0.1%
0.00%0.0%
Q4 2022$6,820,903
-29.2%
668,061
+2.0%
0.00%
-33.3%
Q3 2022$9,637,000
+184.9%
654,662
+107.7%
0.00%
+200.0%
Q2 2022$3,383,000
+8.3%
315,256
+8.8%
0.00%0.0%
Q1 2022$3,125,000
+81.1%
289,846
+174.2%
0.00%0.0%
Q4 2021$1,726,000
-21.8%
105,704
+2.6%
0.00%0.0%
Q3 2021$2,206,000102,9900.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 1,300,000$13,273,0008.92%
Miura Global Management 780,000$7,963,8004.01%
RA Capital Management 13,381,054$136,620,5612.77%
HHLR ADVISORS, LTD. 8,684,530$88,669,0511.87%
Brown Capital Management 5,107,878$52,151,4340.86%
Perceptive Advisors 1,289,534$13,166,1420.37%
Hillsdale Investment Management Inc. 344,529$3,517,6410.30%
PURA VIDA INVESTMENTS, LLC 420,749$4,295,8470.22%
FOX RUN MANAGEMENT, L.L.C. 19,881$202,9850.08%
INNOVIS ASSET MANAGEMENT LLC 14,565$148,7090.07%
View complete list of CYTEK BIOSCIENCES INC shareholders